P
Pirouette Pharma
Pirouette Medical develops a portable, intuitive, and easy-to-use auto-injector
About Pirouette Pharma
Pirouette Medical is a pioneering company in the healthcare sector, specializing in the development of innovative medical devices. Founded by three rocket scientists, the company aims to improve the human condition by placing healthcare directly in the hands of patients. Pirouette Medical's flagship product, QuicPush, is a revolutionary autoinjector designed to provide convenient healthcare solutions anywhere, making it as easy as pushing a button. The company primarily serves patients who require regular medication administration, offering a user-friendly and efficient alternative to traditional methods. Operating in the medical device market, Pirouette Medical employs a business model that focuses on the sale of its patented devices. Revenue is generated through direct sales to consumers and partnerships with healthcare providers and institutions. The company's leadership team includes experienced professionals with backgrounds in aeronautical engineering, biomedical engineering, and medical device industries, ensuring a robust and innovative approach to healthcare solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Portsmouth, United States
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 60.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Healthcare Technologies, Hard Tech, YC S21, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2024 | $5.1M | $55M | Y Combinator · Safar Partners · Wefunder · Liquid 2 Ventures | ↗ |
| EARLY VCEquity / VC | Sep 2021 | $7M | $28M | Undisclosed | — |
Growth signals
Latest recorded traffic for Pirouette Pharma is 840 monthly website visits, up 6.3% over the last three months. Pirouette Pharma's team declined 21.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pirouette Pharma in the Portsmouth ecosystem
The Pirouette Pharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A4 investors entered at this stage
Safar Partners
Wefunder
Liquid 2 Ventures
Gaingels
Other known investors4 additional known investors
515 Ventures
Founders Inc
Harbor Street Ventures
Helium-3 Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pirouette Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pirouette Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











